One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1182/blood.v130.suppl_1.650.650
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Dec 7, 2017 |
 Citations: 10 |
Affiliation: Emory University, University Hospital Cologne, Mayo Clinic, Memorial Sloan Kettering Cancer Center, General University Hospital in Prague, BC Cancer Agency, Karmanos Cancer Institute, Churchill Hospital, The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, University of Bologna, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Humanitas University, Los Angeles Medical Center, Bristol-Myers Squibb (United States), Princess Margaret Cancer Centre, University of Toronto
Nivolumab Treatment Beyond Investigator-Assessed Progression: Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 Checkmate 205 Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
